Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Reliable Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic epitope tag widely used in molecular biology for the detection and purification of HA-tagged fusion proteins (APExBIO). It achieves competitive binding to anti-HA antibodies, enabling efficient elution during immunoprecipitation assays. The peptide is characterized by high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), as well as >98% purity confirmed by HPLC and mass spectrometry. Its use streamlines protein-protein interaction studies, improves workflow reproducibility, and supports advanced research applications (Wei et al., 2021).

Biological Rationale

The HA tag is derived from the human influenza virus hemagglutinin protein, specifically from amino acids 98–106 (YPYDVPDYA) (APExBIO). This linear epitope is recognized with high specificity by anti-HA monoclonal antibodies, such as 12CA5, which enables unambiguous detection and purification of HA-tagged proteins in diverse cell types and species (LabPe). The tag’s small size minimizes perturbation of protein structure or function, making it an ideal tool for studying protein localization, interaction, and function in live cells or lysates. In exosome research, HA-tagged constructs facilitate the tracking and enrichment of proteins within extracellular vesicles, supporting mechanistic studies of cell signaling and vesicular transport (Wei et al., 2021).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide acts as a competitive ligand for anti-HA antibodies. When added to an immunoprecipitation (IP) or affinity purification workflow, the synthetic HA peptide binds to the antibody’s antigen recognition site, displacing HA-tagged fusion proteins from antibody-conjugated beads (Epitope Peptide). This enables the selective elution of targeted proteins under mild, nondenaturing conditions, preserving native protein conformation and activity. The high affinity and specificity of the anti-HA/HA peptide interaction ensures minimal background and high recovery rates. Sequence conservation and lack of post-translational modifications in the synthetic peptide further guarantee reproducibility across experiments and platforms.

Evidence & Benchmarks

• APExBIO’s HA tag peptide (A6004) achieves >98% purity, as verified by high-performance liquid chromatography (HPLC) and mass spectrometry analyses (product page).
• The HA peptide displays solubility of ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water, supporting its use in a broad range of buffer systems (APExBIO).
• HA tag immunoprecipitation enables the isolation of HA-tagged exosomal proteins for mechanistic studies of vesicle biogenesis and secretion (Wei et al., 2021, DOI:10.1038/s41422-020-00409-1).
• Competitive elution using the synthetic HA peptide preserves protein-protein interactions, unlike harsh denaturants (Angiotensin 1-2-1-9).
• Validated workflows demonstrate increased reproducibility and sensitivity in protein detection when using high-purity HA tag peptides compared to conventional tags (Angiotensin 1-2-1-9).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide provides a versatile platform for:

• Protein detection by Western blot, ELISA, and immunofluorescence using anti-HA antibody reagents.
• Affinity purification and immunoprecipitation of HA-tagged fusion proteins from cell lysates or conditioned media.
• Elution of HA-tagged proteins from magnetic beads or agarose via competitive displacement.
• Mapping protein-protein interactions in native conditions (Angiotensin 1-2-1-9).
• Tracking and enrichment of tagged proteins in exosome and extracellular vesicle research (Wei et al., 2021).

Compared to similar tags, the HA peptide offers high specificity, minimal immunogenicity, and validated performance in mammalian, yeast, and plant systems (LabPe). For an in-depth workflow guide, see this advanced protocol resource—this article extends those findings by providing quantitative benchmarks and highlighting recent mechanistic insights.

Common Pitfalls or Misconceptions

• Not suitable for in vivo immunization: The HA peptide is not immunogenic enough for raising new antibodies.
• No direct biological activity: The peptide does not confer influenza virus infectivity or function.
• Low abundance targets: Detection sensitivity depends on the expression level of the HA-tagged protein; false negatives may occur at low abundance.
• Sequence context matters: Fusion to certain N- or C-terminal domains can impair antibody accessibility to the tag.
• Storage limitations: Long-term peptide solutions are unstable and may degrade; always store lyophilized at -20°C.

Workflow Integration & Parameters

The HA peptide (A6004) is supplied as a lyophilized powder with >98% purity. For dissolution, the peptide can be reconstituted in DMSO, ethanol, or water at concentrations up to 100.4 mg/mL (ethanol). Recommended storage is desiccated at -20°C; avoid repeated freeze-thaw cycles and prolonged storage of diluted solutions (APExBIO).

In immunoprecipitation, incubate anti-HA beads with lysate containing HA-tagged proteins, wash, then elute with HA peptide (typically 1 mg/mL in PBS) for 30 minutes at 4°C. The peptide’s high solubility ensures compatibility with a wide range of buffers and detergents. For troubleshooting and advanced use-cases, see this guide—the present article updates those protocols with stability and purity data for A6004.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide from APExBIO (A6004) sets a standard for purity, solubility, and reliability in protein tagging and purification workflows. Its broad compatibility, reproducibility, and minimal interference with protein function support its adoption in advanced molecular biology and exosome research. Ongoing developments in antibody specificity and workflow automation are expected to expand the utility of HA tag systems for both routine and high-throughput applications. For further reading, see this overview, which this article complements by providing quantitative benchmarks and emphasizing mechanistic details relevant to translational research.